id	sid	tid	token	lemma	pos
egc-378	1	1	eglobal	eglobal	PROPN
egc-378	1	2	congress	congress	PROPN
egc-378	1	3	hosted	host	VERB
egc-378	1	4	online	online	ADV
egc-378	1	5	from	from	ADP
egc-378	1	6	dubai	dubai	PROPN
egc-378	1	7	,	,	PUNCT
egc-378	1	8	u.	u.	PROPN
egc-378	1	9	a.	a.	PROPN
egc-378	1	10	e.	e.	PROPN
egc-378	1	11	,	,	PUNCT
egc-378	1	12	e	e	PROPN
egc-378	1	13	conference	conference	NOUN
egc-378	1	14	.	.	PUNCT
egc-378	2	1	date	date	NOUN
egc-378	2	2	:	:	PUNCT
egc-378	2	3	30th	30th	ADJ
egc-378	2	4	august	august	PROPN
egc-378	2	5	2025	2025	NUM
egc-378	2	6	website	website	NOUN
egc-378	2	7	:	:	PUNCT
egc-378	2	8	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-378	2	9	issn	issn	PROPN
egc-378	2	10	(	(	PUNCT
egc-378	2	11	e	e	NOUN
egc-378	2	12	):	):	PUNCT
egc-378	2	13	2836	2836	NUM
egc-378	2	14	-	-	SYM
egc-378	2	15	3612	3612	NUM
egc-378	2	16	6	6	NUM
egc-378	2	17	|	|	ADV
egc-378	2	18	p	p	NOUN
egc-378	2	19	a	a	DET
egc-378	2	20	g	g	NOUN
egc-378	2	21	e	e	NOUN
egc-378	2	22	cytokine	cytokine	NOUN
egc-378	2	23	profile	profile	NOUN
egc-378	2	24	in	in	ADP
egc-378	2	25	progressive	progressive	ADJ
egc-378	2	26	hyperglycemia	hyperglycemia	NOUN
egc-378	2	27	:	:	PUNCT
egc-378	2	28	tnf	tnf	PROPN
egc-378	2	29	-	-	PUNCT
egc-378	2	30	α	α	PROPN
egc-378	2	31	,	,	PUNCT
egc-378	2	32	il-6	il-6	NOUN
egc-378	2	33	and	and	CCONJ
egc-378	2	34	il-10	il-10	NOUN
egc-378	2	35	in	in	ADP
egc-378	2	36	the	the	DET
egc-378	2	37	experiment	experiment	NOUN
egc-378	2	38	pulаtоv	pulаtоv	PROPN
egc-378	2	39	khabibulla	khabibulla	PROPN
egc-378	2	40	khayrullaeyich	khayrullaeyich	PROPN
egc-378	2	41	-	-	PUNCT
egc-378	2	42	ph.d	ph.d	PROPN
egc-378	2	43	.	.	PUNCT
egc-378	3	1	dotsent	dotsent	PROPN
egc-378	3	2	tashkent	tashkent	PROPN
egc-378	3	3	state	state	PROPN
egc-378	3	4	medical	medical	PROPN
egc-378	3	5	university	university	PROPN
egc-378	3	6	(	(	PUNCT
egc-378	3	7	tashkent	tashkent	PROPN
egc-378	3	8	,	,	PUNCT
egc-378	3	9	uzbekistan	uzbekistan	PROPN
egc-378	3	10	)	)	PUNCT
egc-378	3	11	introduction	introduction	NOUN
egc-378	3	12	:	:	PUNCT
egc-378	3	13	diabetes	diabetes	NOUN
egc-378	3	14	mellitus	mellitus	NOUN
egc-378	3	15	and	and	CCONJ
egc-378	3	16	its	its	PRON
egc-378	3	17	primary	primary	ADJ
egc-378	3	18	characteristic	characteristic	NOUN
egc-378	3	19	,	,	PUNCT
egc-378	3	20	hyperglycemia	hyperglycemia	NOUN
egc-378	3	21	,	,	PUNCT
egc-378	3	22	cause	cause	VERB
egc-378	3	23	metabolic	metabolic	NOUN
egc-378	3	24	disturbances	disturbance	NOUN
egc-378	3	25	accompanied	accompany	VERB
egc-378	3	26	by	by	ADP
egc-378	3	27	intensified	intensify	VERB
egc-378	3	28	inflammatory	inflammatory	ADJ
egc-378	3	29	processes	process	NOUN
egc-378	3	30	.	.	PUNCT
egc-378	4	1	levels	level	NOUN
egc-378	4	2	of	of	ADP
egc-378	4	3	pro	pro	ADJ
egc-378	4	4	-	-	ADJ
egc-378	4	5	inflammatory	inflammatory	ADJ
egc-378	4	6	cytokines	cytokine	NOUN
egc-378	4	7	such	such	ADJ
egc-378	4	8	as	as	ADP
egc-378	4	9	tnf	tnf	PROPN
egc-378	4	10	-	-	PUNCT
egc-378	4	11	α	α	PROPN
egc-378	4	12	and	and	CCONJ
egc-378	4	13	il-6	il-6	NOUN
egc-378	4	14	increase	increase	NOUN
egc-378	4	15	,	,	PUNCT
egc-378	4	16	while	while	SCONJ
egc-378	4	17	anti	anti	ADJ
egc-378	4	18	-	-	ADJ
egc-378	4	19	inflammatory	inflammatory	ADJ
egc-378	4	20	cytokines	cytokine	NOUN
egc-378	4	21	like	like	ADP
egc-378	4	22	il-10	il-10	NOUN
egc-378	4	23	decrease	decrease	NOUN
egc-378	4	24	.	.	PUNCT
egc-378	5	1	this	this	DET
egc-378	5	2	imbalance	imbalance	NOUN
egc-378	5	3	may	may	AUX
egc-378	5	4	exacerbate	exacerbate	VERB
egc-378	5	5	the	the	DET
egc-378	5	6	complications	complication	NOUN
egc-378	5	7	of	of	ADP
egc-378	5	8	the	the	DET
egc-378	5	9	disease	disease	NOUN
egc-378	5	10	.	.	PUNCT
egc-378	6	1	objective	objective	NOUN
egc-378	6	2	:	:	PUNCT
egc-378	6	3	to	to	PART
egc-378	6	4	investigate	investigate	VERB
egc-378	6	5	the	the	DET
egc-378	6	6	dynamics	dynamic	NOUN
egc-378	6	7	of	of	ADP
egc-378	6	8	hyperglycemia	hyperglycemia	NOUN
egc-378	6	9	and	and	CCONJ
egc-378	6	10	associated	associated	ADJ
egc-378	6	11	changes	change	NOUN
egc-378	6	12	in	in	ADP
egc-378	6	13	tnf	tnf	PROPN
egc-378	6	14	-	-	PUNCT
egc-378	6	15	α	α	PROPN
egc-378	6	16	,	,	PUNCT
egc-378	6	17	il-6	il-6	NOUN
egc-378	6	18	,	,	PUNCT
egc-378	6	19	and	and	CCONJ
egc-378	6	20	il-10	il-10	DET
egc-378	6	21	cytokine	cytokine	ADJ
egc-378	6	22	levels	level	NOUN
egc-378	6	23	in	in	ADP
egc-378	6	24	laboratory	laboratory	NOUN
egc-378	6	25	animals	animal	NOUN
egc-378	6	26	,	,	PUNCT
egc-378	6	27	as	as	ADV
egc-378	6	28	well	well	ADV
egc-378	6	29	as	as	ADP
egc-378	6	30	to	to	PART
egc-378	6	31	analyze	analyze	VERB
egc-378	6	32	the	the	DET
egc-378	6	33	relationships	relationship	NOUN
egc-378	6	34	between	between	ADP
egc-378	6	35	these	these	DET
egc-378	6	36	indicators	indicator	NOUN
egc-378	6	37	.	.	PUNCT
egc-378	7	1	materials	material	NOUN
egc-378	7	2	and	and	CCONJ
egc-378	7	3	methods	method	NOUN
egc-378	7	4	:	:	PUNCT
egc-378	7	5	in	in	ADP
egc-378	7	6	this	this	DET
egc-378	7	7	study	study	NOUN
egc-378	7	8	,	,	PUNCT
egc-378	7	9	hyperglycemia	hyperglycemia	NOUN
egc-378	7	10	was	be	AUX
egc-378	7	11	modeled	model	VERB
egc-378	7	12	in	in	ADP
egc-378	7	13	laboratory	laboratory	NOUN
egc-378	7	14	rats	rat	NOUN
egc-378	7	15	.	.	PUNCT
egc-378	8	1	levels	level	NOUN
egc-378	8	2	of	of	ADP
egc-378	8	3	glucose	glucose	NOUN
egc-378	8	4	and	and	CCONJ
egc-378	8	5	cytokines	cytokine	NOUN
egc-378	8	6	were	be	AUX
egc-378	8	7	measured	measure	VERB
egc-378	8	8	at	at	ADP
egc-378	8	9	30	30	NUM
egc-378	8	10	,	,	PUNCT
egc-378	8	11	60	60	NUM
egc-378	8	12	,	,	PUNCT
egc-378	8	13	90	90	NUM
egc-378	8	14	,	,	PUNCT
egc-378	8	15	and	and	CCONJ
egc-378	8	16	120	120	NUM
egc-378	8	17	days	day	NOUN
egc-378	8	18	.	.	PUNCT
egc-378	9	1	changes	change	NOUN
egc-378	9	2	were	be	AUX
egc-378	9	3	analyzed	analyze	VERB
egc-378	9	4	using	use	VERB
egc-378	9	5	percentage	percentage	NOUN
egc-378	9	6	and	and	CCONJ
egc-378	9	7	fold	fold	ADJ
egc-378	9	8	-	-	PUNCT
egc-378	9	9	change	change	NOUN
egc-378	9	10	comparisons	comparison	NOUN
egc-378	9	11	.	.	PUNCT
egc-378	10	1	results	result	NOUN
egc-378	10	2	:	:	PUNCT
egc-378	10	3	throughout	throughout	ADP
egc-378	10	4	the	the	DET
egc-378	10	5	duration	duration	NOUN
egc-378	10	6	of	of	ADP
egc-378	10	7	the	the	DET
egc-378	10	8	experiment	experiment	NOUN
egc-378	10	9	,	,	PUNCT
egc-378	10	10	we	we	PRON
egc-378	10	11	observed	observe	VERB
egc-378	10	12	a	a	DET
egc-378	10	13	significant	significant	ADJ
egc-378	10	14	elevation	elevation	NOUN
egc-378	10	15	in	in	ADP
egc-378	10	16	blood	blood	NOUN
egc-378	10	17	glucose	glucose	NOUN
egc-378	10	18	levels	level	NOUN
egc-378	10	19	,	,	PUNCT
egc-378	10	20	increasing	increase	VERB
egc-378	10	21	approximately	approximately	ADV
egc-378	10	22	threefold	threefold	ADV
egc-378	10	23	compared	compare	VERB
egc-378	10	24	to	to	ADP
egc-378	10	25	baseline	baseline	VERB
egc-378	10	26	measurements	measurement	NOUN
egc-378	10	27	.	.	PUNCT
egc-378	11	1	this	this	DET
egc-378	11	2	substantial	substantial	ADJ
egc-378	11	3	rise	rise	NOUN
egc-378	11	4	in	in	ADP
egc-378	11	5	glucose	glucose	NOUN
egc-378	11	6	concentration	concentration	NOUN
egc-378	11	7	provides	provide	VERB
egc-378	11	8	a	a	DET
egc-378	11	9	clear	clear	ADJ
egc-378	11	10	indication	indication	NOUN
egc-378	11	11	of	of	ADP
egc-378	11	12	the	the	DET
egc-378	11	13	hyperglycemic	hyperglycemic	ADJ
egc-378	11	14	state	state	NOUN
egc-378	11	15	induced	induce	VERB
egc-378	11	16	within	within	ADP
egc-378	11	17	the	the	DET
egc-378	11	18	experimental	experimental	ADJ
egc-378	11	19	model	model	NOUN
egc-378	11	20	.	.	PUNCT
egc-378	12	1	furthermore	furthermore	ADV
egc-378	12	2	,	,	PUNCT
egc-378	12	3	analysis	analysis	NOUN
egc-378	12	4	of	of	ADP
egc-378	12	5	cytokine	cytokine	ADJ
egc-378	12	6	profiles	profile	NOUN
egc-378	12	7	revealed	reveal	VERB
egc-378	12	8	a	a	DET
egc-378	12	9	marked	marked	ADJ
egc-378	12	10	increase	increase	NOUN
egc-378	12	11	in	in	ADP
egc-378	12	12	the	the	DET
egc-378	12	13	levels	level	NOUN
egc-378	12	14	of	of	ADP
egc-378	12	15	both	both	DET
egc-378	12	16	tumor	tumor	NOUN
egc-378	12	17	necrosis	necrosis	NOUN
egc-378	12	18	factor	factor	NOUN
egc-378	12	19	-	-	PUNCT
egc-378	12	20	alpha	alpha	NOUN
egc-378	12	21	(	(	PUNCT
egc-378	12	22	tnf	tnf	PROPN
egc-378	12	23	-	-	PUNCT
egc-378	12	24	α	α	NOUN
egc-378	12	25	)	)	PUNCT
egc-378	12	26	and	and	CCONJ
egc-378	12	27	interleukin-6	interleukin-6	NUM
egc-378	12	28	(	(	PUNCT
egc-378	12	29	il-6	il-6	NUM
egc-378	12	30	)	)	PUNCT
egc-378	12	31	.	.	PUNCT
egc-378	13	1	tnf	tnf	PROPN
egc-378	13	2	-	-	PUNCT
egc-378	13	3	α	α	PROPN
egc-378	13	4	levels	level	NOUN
egc-378	13	5	rose	rise	VERB
egc-378	13	6	by	by	ADP
egc-378	13	7	a	a	DET
egc-378	13	8	factor	factor	NOUN
egc-378	13	9	of	of	ADP
egc-378	13	10	2	2	NUM
egc-378	13	11	to	to	ADP
egc-378	13	12	3	3	NUM
egc-378	13	13	,	,	PUNCT
egc-378	13	14	signifying	signify	VERB
egc-378	13	15	a	a	DET
egc-378	13	16	considerable	considerable	ADJ
egc-378	13	17	activation	activation	NOUN
egc-378	13	18	of	of	ADP
egc-378	13	19	this	this	DET
egc-378	13	20	potent	potent	ADJ
egc-378	13	21	pro	pro	ADJ
egc-378	13	22	-	-	ADJ
egc-378	13	23	inflammatory	inflammatory	ADJ
egc-378	13	24	mediator	mediator	NOUN
egc-378	13	25	,	,	PUNCT
egc-378	13	26	while	while	SCONJ
egc-378	13	27	il-6	il-6	PRON
egc-378	13	28	,	,	PUNCT
egc-378	13	29	another	another	DET
egc-378	13	30	key	key	ADJ
egc-378	13	31	cytokine	cytokine	NOUN
egc-378	13	32	involved	involve	VERB
egc-378	13	33	in	in	ADP
egc-378	13	34	acute	acute	ADJ
egc-378	13	35	and	and	CCONJ
egc-378	13	36	chronic	chronic	ADJ
egc-378	13	37	inflammation	inflammation	NOUN
egc-378	13	38	,	,	PUNCT
egc-378	13	39	also	also	ADV
egc-378	13	40	demonstrated	demonstrate	VERB
egc-378	13	41	a	a	DET
egc-378	13	42	2	2	NUM
egc-378	13	43	to	to	PART
egc-378	13	44	3	3	NUM
egc-378	13	45	-	-	ADJ
egc-378	13	46	fold	fold	ADJ
egc-378	13	47	increase	increase	NOUN
egc-378	13	48	.	.	PUNCT
egc-378	14	1	in	in	ADP
egc-378	14	2	stark	stark	ADJ
egc-378	14	3	contrast	contrast	NOUN
egc-378	14	4	to	to	ADP
egc-378	14	5	these	these	DET
egc-378	14	6	pro	pro	ADJ
egc-378	14	7	-	-	ADJ
egc-378	14	8	inflammatory	inflammatory	ADJ
egc-378	14	9	trends	trend	NOUN
egc-378	14	10	,	,	PUNCT
egc-378	14	11	interleukin-10	interleukin-10	PROPN
egc-378	14	12	(	(	PUNCT
egc-378	14	13	il-10	il-10	NUM
egc-378	14	14	)	)	PUNCT
egc-378	14	15	,	,	PUNCT
egc-378	14	16	a	a	DET
egc-378	14	17	crucial	crucial	ADJ
egc-378	14	18	antiinflammatory	antiinflammatory	NOUN
egc-378	14	19	cytokine	cytokine	NOUN
egc-378	14	20	responsible	responsible	ADJ
egc-378	14	21	for	for	ADP
egc-378	14	22	modulating	modulate	VERB
egc-378	14	23	immune	immune	ADJ
egc-378	14	24	responses	response	NOUN
egc-378	14	25	and	and	CCONJ
egc-378	14	26	resolving	resolve	VERB
egc-378	14	27	inflammation	inflammation	NOUN
egc-378	14	28	,	,	PUNCT
egc-378	14	29	exhibited	exhibit	VERB
egc-378	14	30	a	a	DET
egc-378	14	31	notable	notable	ADJ
egc-378	14	32	decrease	decrease	NOUN
egc-378	14	33	.	.	PUNCT
egc-378	15	1	the	the	DET
egc-378	15	2	reduction	reduction	NOUN
egc-378	15	3	in	in	ADP
egc-378	15	4	ilhttps://eglobalcongress.com/index.php/egc	ilhttps://eglobalcongress.com/index.php/egc	PROPN
egc-378	15	5	eglobal	eglobal	PROPN
egc-378	15	6	congress	congress	PROPN
egc-378	15	7	hosted	host	VERB
egc-378	15	8	online	online	ADV
egc-378	15	9	from	from	ADP
egc-378	15	10	dubai	dubai	PROPN
egc-378	15	11	,	,	PUNCT
egc-378	15	12	u.	u.	PROPN
egc-378	15	13	a.	a.	PROPN
egc-378	15	14	e.	e.	PROPN
egc-378	15	15	,	,	PUNCT
egc-378	15	16	e	e	PROPN
egc-378	15	17	conference	conference	NOUN
egc-378	15	18	.	.	PUNCT
egc-378	16	1	date	date	NOUN
egc-378	16	2	:	:	PUNCT
egc-378	16	3	30th	30th	ADJ
egc-378	16	4	august	august	PROPN
egc-378	16	5	2025	2025	NUM
egc-378	16	6	website	website	NOUN
egc-378	16	7	:	:	PUNCT
egc-378	16	8	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-378	16	9	issn	issn	PROPN
egc-378	16	10	(	(	PUNCT
egc-378	16	11	e	e	NOUN
egc-378	16	12	):	):	PUNCT
egc-378	16	13	2836	2836	NUM
egc-378	16	14	-	-	SYM
egc-378	16	15	3612	3612	NUM
egc-378	16	16	7	7	NUM
egc-378	16	17	|	|	ADV
egc-378	16	18	p	p	X
egc-378	16	19	a	a	DET
egc-378	16	20	g	g	NOUN
egc-378	16	21	e	e	NOUN
egc-378	16	22	10	10	NUM
egc-378	16	23	levels	level	NOUN
egc-378	16	24	was	be	AUX
egc-378	16	25	observed	observe	VERB
egc-378	16	26	to	to	PART
egc-378	16	27	be	be	AUX
egc-378	16	28	nearly	nearly	ADV
egc-378	16	29	proportional	proportional	ADJ
egc-378	16	30	to	to	ADP
egc-378	16	31	the	the	DET
egc-378	16	32	increases	increase	NOUN
egc-378	16	33	in	in	ADP
egc-378	16	34	tnf	tnf	PROPN
egc-378	16	35	-	-	PUNCT
egc-378	16	36	α	α	PROPN
egc-378	16	37	and	and	CCONJ
egc-378	16	38	il-6	il-6	NOUN
egc-378	16	39	,	,	PUNCT
egc-378	16	40	suggesting	suggest	VERB
egc-378	16	41	a	a	DET
egc-378	16	42	systemic	systemic	ADJ
egc-378	16	43	shift	shift	NOUN
egc-378	16	44	in	in	ADP
egc-378	16	45	the	the	DET
egc-378	16	46	balance	balance	NOUN
egc-378	16	47	of	of	ADP
egc-378	16	48	inflammatory	inflammatory	ADJ
egc-378	16	49	mediators	mediator	NOUN
egc-378	16	50	.	.	PUNCT
egc-378	17	1	collectively	collectively	ADV
egc-378	17	2	,	,	PUNCT
egc-378	17	3	these	these	DET
egc-378	17	4	findings	finding	NOUN
egc-378	17	5	strongly	strongly	ADV
egc-378	17	6	indicate	indicate	VERB
egc-378	17	7	a	a	DET
egc-378	17	8	deepening	deepening	NOUN
egc-378	17	9	,	,	PUNCT
egc-378	17	10	or	or	CCONJ
egc-378	17	11	intensification	intensification	NOUN
egc-378	17	12	,	,	PUNCT
egc-378	17	13	of	of	ADP
egc-378	17	14	inflammatory	inflammatory	ADJ
egc-378	17	15	responses	response	NOUN
egc-378	17	16	directly	directly	ADV
egc-378	17	17	associated	associate	VERB
egc-378	17	18	with	with	ADP
egc-378	17	19	the	the	DET
egc-378	17	20	induced	induced	ADJ
egc-378	17	21	hyperglycemia	hyperglycemia	NOUN
egc-378	17	22	,	,	PUNCT
egc-378	17	23	suggesting	suggest	VERB
egc-378	17	24	a	a	DET
egc-378	17	25	feedback	feedback	NOUN
egc-378	17	26	loop	loop	NOUN
egc-378	17	27	where	where	SCONJ
egc-378	17	28	elevated	elevated	ADJ
egc-378	17	29	glucose	glucose	NOUN
egc-378	17	30	contributes	contribute	VERB
egc-378	17	31	to	to	ADP
egc-378	17	32	heightened	heighten	VERB
egc-378	17	33	inflammation	inflammation	NOUN
egc-378	17	34	.	.	PUNCT
egc-378	18	1	conclusion	conclusion	NOUN
egc-378	18	2	:	:	PUNCT
egc-378	18	3	our	our	PRON
egc-378	18	4	research	research	NOUN
egc-378	18	5	demonstrates	demonstrate	VERB
egc-378	18	6	that	that	DET
egc-378	18	7	hyperglycemia	hyperglycemia	NOUN
egc-378	18	8	,	,	PUNCT
egc-378	18	9	or	or	CCONJ
egc-378	18	10	elevated	elevate	VERB
egc-378	18	11	blood	blood	NOUN
egc-378	18	12	glucose	glucose	NOUN
egc-378	18	13	,	,	PUNCT
egc-378	18	14	significantly	significantly	ADV
egc-378	18	15	enhances	enhance	VERB
egc-378	18	16	the	the	DET
egc-378	18	17	activity	activity	NOUN
egc-378	18	18	of	of	ADP
egc-378	18	19	pro	pro	ADJ
egc-378	18	20	-	-	ADJ
egc-378	18	21	inflammatory	inflammatory	ADJ
egc-378	18	22	cytokines	cytokine	NOUN
egc-378	18	23	such	such	ADJ
egc-378	18	24	as	as	ADP
egc-378	18	25	tnf	tnf	PROPN
egc-378	18	26	-	-	PUNCT
egc-378	18	27	α	α	PROPN
egc-378	18	28	and	and	CCONJ
egc-378	18	29	il-6	il-6	NOUN
egc-378	18	30	-hile	-hile	NOUN
egc-378	18	31	simultaneously	simultaneously	ADV
egc-378	18	32	suppressing	suppress	VERB
egc-378	18	33	the	the	DET
egc-378	18	34	production	production	NOUN
egc-378	18	35	and	and	CCONJ
egc-378	18	36	function	function	NOUN
egc-378	18	37	of	of	ADP
egc-378	18	38	anti	anti	ADJ
egc-378	18	39	-	-	ADJ
egc-378	18	40	inflammatory	inflammatory	ADJ
egc-378	18	41	cytokines	cytokine	NOUN
egc-378	18	42	like	like	ADP
egc-378	18	43	il-10	il-10	NOUN
egc-378	18	44	in	in	ADP
egc-378	18	45	laboratory	laboratory	NOUN
egc-378	18	46	animals	animal	NOUN
egc-378	18	47	.	.	PUNCT
egc-378	19	1	this	this	DET
egc-378	19	2	observation	observation	NOUN
egc-378	19	3	highlights	highlight	VERB
egc-378	19	4	the	the	DET
egc-378	19	5	complex	complex	ADJ
egc-378	19	6	and	and	CCONJ
egc-378	19	7	often	often	ADV
egc-378	19	8	bidirectional	bidirectional	ADJ
egc-378	19	9	interplay	interplay	NOUN
egc-378	19	10	between	between	ADP
egc-378	19	11	metabolic	metabolic	NOUN
egc-378	19	12	disturbances	disturbance	NOUN
egc-378	19	13	,	,	PUNCT
egc-378	19	14	specifically	specifically	ADV
egc-378	19	15	hyperglycemia	hyperglycemia	NOUN
egc-378	19	16	,	,	PUNCT
egc-378	19	17	and	and	CCONJ
egc-378	19	18	inflammatory	inflammatory	ADJ
egc-378	19	19	processes	process	NOUN
egc-378	19	20	within	within	ADP
egc-378	19	21	the	the	DET
egc-378	19	22	body	body	NOUN
egc-378	19	23	.	.	PUNCT
egc-378	20	1	for	for	ADP
egc-378	20	2	instance	instance	NOUN
egc-378	20	3	,	,	PUNCT
egc-378	20	4	the	the	DET
egc-378	20	5	increased	increase	VERB
egc-378	20	6	tnf	tnf	PROPN
egc-378	20	7	-	-	PUNCT
egc-378	20	8	α	α	PROPN
egc-378	20	9	could	could	AUX
egc-378	20	10	contribute	contribute	VERB
egc-378	20	11	to	to	ADP
egc-378	20	12	vascular	vascular	ADJ
egc-378	20	13	dysfunction	dysfunction	NOUN
egc-378	20	14	,	,	PUNCT
egc-378	20	15	while	while	SCONJ
egc-378	20	16	elevated	elevated	ADJ
egc-378	20	17	il-6	il-6	NOUN
egc-378	20	18	may	may	AUX
egc-378	20	19	exacerbate	exacerbate	VERB
egc-378	20	20	insulin	insulin	NOUN
egc-378	20	21	resistance	resistance	NOUN
egc-378	20	22	.	.	PUNCT
egc-378	21	1	the	the	DET
egc-378	21	2	suppression	suppression	NOUN
egc-378	21	3	of	of	ADP
egc-378	21	4	il-10	il-10	PRON
egc-378	21	5	,	,	PUNCT
egc-378	21	6	which	which	PRON
egc-378	21	7	normally	normally	ADV
egc-378	21	8	dampens	dampen	VERB
egc-378	21	9	inflammation	inflammation	NOUN
egc-378	21	10	,	,	PUNCT
egc-378	21	11	further	far	ADV
egc-378	21	12	amplifies	amplify	VERB
egc-378	21	13	this	this	DET
egc-378	21	14	pro	pro	ADJ
egc-378	21	15	-	-	ADJ
egc-378	21	16	inflammatory	inflammatory	ADJ
egc-378	21	17	state	state	NOUN
egc-378	21	18	.	.	PUNCT
egc-378	22	1	these	these	DET
egc-378	22	2	results	result	NOUN
egc-378	22	3	are	be	AUX
egc-378	22	4	crucial	crucial	ADJ
egc-378	22	5	for	for	ADP
egc-378	22	6	a	a	DET
egc-378	22	7	more	more	ADV
egc-378	22	8	comprehensive	comprehensive	ADJ
egc-378	22	9	understanding	understanding	NOUN
egc-378	22	10	of	of	ADP
egc-378	22	11	the	the	DET
egc-378	22	12	pathophysiology	pathophysiology	NOUN
egc-378	22	13	of	of	ADP
egc-378	22	14	diabetes	diabetes	NOUN
egc-378	22	15	,	,	PUNCT
egc-378	22	16	a	a	DET
egc-378	22	17	disease	disease	NOUN
egc-378	22	18	characterized	characterize	VERB
egc-378	22	19	by	by	ADP
egc-378	22	20	chronic	chronic	ADJ
egc-378	22	21	hyperglycemia	hyperglycemia	NOUN
egc-378	22	22	and	and	CCONJ
egc-378	22	23	associated	associated	ADJ
egc-378	22	24	inflammation	inflammation	NOUN
egc-378	22	25	.	.	PUNCT
egc-378	23	1	specifically	specifically	ADV
egc-378	23	2	,	,	PUNCT
egc-378	23	3	they	they	PRON
egc-378	23	4	provide	provide	VERB
egc-378	23	5	valuable	valuable	ADJ
egc-378	23	6	insights	insight	NOUN
egc-378	23	7	into	into	ADP
egc-378	23	8	the	the	DET
egc-378	23	9	mechanisms	mechanism	NOUN
egc-378	23	10	driving	drive	VERB
egc-378	23	11	the	the	DET
egc-378	23	12	development	development	NOUN
egc-378	23	13	of	of	ADP
egc-378	23	14	diabetic	diabetic	ADJ
egc-378	23	15	complications	complication	NOUN
egc-378	23	16	,	,	PUNCT
egc-378	23	17	such	such	ADJ
egc-378	23	18	as	as	ADP
egc-378	23	19	cardiovascular	cardiovascular	ADJ
egc-378	23	20	disease	disease	NOUN
egc-378	23	21	,	,	PUNCT
egc-378	23	22	neuropathy	neuropathy	ADJ
egc-378	23	23	,	,	PUNCT
egc-378	23	24	and	and	CCONJ
egc-378	23	25	nephropathy	nephropathy	NOUN
egc-378	23	26	.	.	PUNCT
egc-378	24	1	moreover	moreover	ADV
egc-378	24	2	,	,	PUNCT
egc-378	24	3	these	these	DET
egc-378	24	4	findings	finding	NOUN
egc-378	24	5	offer	offer	VERB
egc-378	24	6	a	a	DET
egc-378	24	7	strong	strong	ADJ
egc-378	24	8	rationale	rationale	NOUN
egc-378	24	9	for	for	ADP
egc-378	24	10	developing	develop	VERB
egc-378	24	11	and	and	CCONJ
egc-378	24	12	refining	refine	VERB
egc-378	24	13	effective	effective	ADJ
egc-378	24	14	treatment	treatment	NOUN
egc-378	24	15	strategies	strategy	NOUN
egc-378	24	16	that	that	PRON
egc-378	24	17	target	target	VERB
egc-378	24	18	both	both	CCONJ
egc-378	24	19	metabolic	metabolic	NOUN
egc-378	24	20	control	control	NOUN
egc-378	24	21	and	and	CCONJ
egc-378	24	22	the	the	DET
egc-378	24	23	underlying	underlie	VERB
egc-378	24	24	inflammatory	inflammatory	ADJ
egc-378	24	25	processes	process	NOUN
egc-378	24	26	in	in	ADP
egc-378	24	27	individuals	individual	NOUN
egc-378	24	28	with	with	ADP
egc-378	24	29	diabetes	diabetes	NOUN
egc-378	24	30	,	,	PUNCT
egc-378	24	31	potentially	potentially	ADV
egc-378	24	32	leading	lead	VERB
egc-378	24	33	to	to	ADP
egc-378	24	34	improved	improve	VERB
egc-378	24	35	patient	patient	ADJ
egc-378	24	36	outcomes	outcome	NOUN
egc-378	24	37	and	and	CCONJ
egc-378	24	38	a	a	DET
egc-378	24	39	reduction	reduction	NOUN
egc-378	24	40	in	in	ADP
egc-378	24	41	the	the	DET
egc-378	24	42	burden	burden	NOUN
egc-378	24	43	of	of	ADP
egc-378	24	44	this	this	DET
egc-378	24	45	widespread	widespread	ADJ
egc-378	24	46	disease	disease	NOUN
egc-378	24	47	.	.	PUNCT
egc-378	25	1	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN